RxDoctor Payments Data

Emily Pepyne, DPM

Podiatrist · North Easton, MANPI 1841604865

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Stryker at 35.0% of the total. 2025 is the largest year on record at $1,997, 2.9 times the $693 reported in 2019. Among podiatrist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,391in general payments, 2019–2025

Across 89 payments — averaging $71.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Crossroads Extremity Systems, LLC$1K
  • Treace Medical Concepts, Inc.$1K
  • Smith+Nephew$486
  • Arthrex$415
  • Kairos Surgical Inc$85
  • plus $529 from 18 others

What the payments were for

  • Travel & lodging$2,94846%
  • Food & beverage$2,97247%
  • Education$3786%
  • Gifts$941%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,391 in reported general payments places this provider in the 90th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$53,223
Medicare patients
175
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin60$729
Ciclopirox22$477
Cyclobenzaprine Hcl34$470
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$238
Colchicine14$130
Terbinafine Hcl12$90
Meloxicam20$83
Cephalexin14$53

Paid to pharmacies, not to this prescriber.

Other podiatrist in North Easton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →